ArticleBMC genomics2025
Genome mining the black-yeast Aureobasidium pullulans NRRL 62031 for biotechnological traits.
Article in BMC genomics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Stress-Induced Cross-Protection and Combined Stress Responses in Extremotolerant Black Yeasts.Journal of fungi (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Aureobasidium pullulans is a yeast-like fungus known for its commercial biomanufacturing of pullulan. This study explores the genome of A. pullulans NRRL 62031, highlighting its biosynthetic potential, metabolic pathways, and physiological traits. Additionally, it demonstrates actual product formation and links molecular features to biotechnological applications. Phylogenetic analysis suggested it might be closely related to Aureobasidium melanogenum. While the functional annotation revealed a wide carbohydrate catabolism, growth evaluation demonstrated that the microbe can utilize not only saccharides but also polyols and organic acids. The extracellular cellulolytic, xylanolytic, and pectinolytic activities were indicated by the formation of visible halos on agar plates. The antiSMASH pipeline, NCBI Blastp alignment, and product qualification confirmed that A. pullulans NRRL 62031 can produce melanin, pullulan, polymalate, and polyol lipids. Moreover, yanuthone D, burnettramic acid A, choline, fructooligosaccharides, gluconic acid, and β-glucan might be synthesized by A. pullulans NRRL 62031. The results clearly show the extraordinary potential of A. pullulans NRRL 62031 as a microbial chassis for valorizing biomass residues into value-added bioproducts. The strong catabolic and anabolic capacities indicate significant promise for biotechnological applications. The results are discussed in the context of metabolic engineering of Aureobasidium.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.